Gastrointestinal malignancies constitute the most common neoplasms with increasing prevalence worldwide, which portend a dismal morbidity and higher mortality rate. Epigenetic phenotypes and field cancerization impute a cutting edge for precursor of several gastrointestinal malignancies; this genetic aberration has been implicated in tumorigenesis and recurrence of gastrointestinal malignancies. This systematic review aims at assessing the effect of epigenetics and field cancerization on carcinogenesis and recurrence of gastrointestinal malignancies. This systematic review and meta-analysis will administer the provisions of Preferred Reporting Items for Systematic Review and Meta-analysis 2020 guideline, and the review protocol has been registered at PROSPERO. The literature search will be executed through several electronic databases including EMBASE, PubMed, Scopus, Web of Science, Cochrane, Global Index Medicus, Semantic Scholar and Google Scholar. All original research articles reporting on the effect of epigenetic signatures, epigenetics and field cancerization on the carcinogenesis and recurrence of gastrointestinal cancers in adults will be included. Only articles with Newcastle–Ottawa Scale score above 4 and low risk of bias based on D1–D5 for randomized controlled trials will be included for a meta-analysis. There is no involvement of human subject participation in this review, thus giving no effect to ethical clearance approval. The evidence report of this review will be disseminated on scientific conferences and will be published to a reputable journal of gastroenterology oncology. This review has been registered at PROSPERO registry ID CRD 42023391339.
Background Gastrointestinal malignancies constitute the most common neoplasms with increasing prevalence worldwide, which portend a dismal morbidity and higher mortality rate. Epigenetic phenotypes and field cancerization impute a cutting edge for precursor of several gastrointestinal malignancies, this genetic aberration have been critically implicated in tumorigenesis and recurrence of gastrointestinal malignancies. There has been a paucity of knowledge about the interface effect between epigenetic signatures, epigenetic phenotype and field cancerization for carcinogenesis and recurrence of disease, a comprehensive analysis on the interplay of these biomarkers would streamline the strategy for epigenetic screening and chemoprevention therapy of gastrointestinal malignancy. This systematic review aims at assessing the effect of epigenetics and field cancerization on carcinogenesis and recurrence of gastrointestinal malignancies. Methods and Analysis This Systematic review and Meta-analysis will administer the provisions of Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) 2020 guideline and the review protocol will be submitted to PROSPERO review registry for registration. The literature search will be executed through several electronic databases including EMBASE, PubMed, Scopus, Web of Science, Cochraine , Global index medicus , semantic scholar and google scholar . All original research articles reporting on the effect of epigenetic signatures, epigenetics and field cancerization on the carcinogenesis and recurrence of gastrointestinal cancers in adults will be included. Only articles with NOS score above 4 and Low ROB based on D1-D5 for RCTs will be included for a Meta-analysis. Ethical Consideration and Dissemination There is no involvement of human subject participation in this review thus giving no effect to ethical implication .The evidence report of this review will be disseminated on scientific conferences and will be published to a reputable journal of gastroenterology oncology. This review has been registered at PROSPERO registry ID CRD 42023391339
BackgroundTraumatic brain injury (TBI) is a critical problem which portends an intensive burden with increased mortality and disability affecting more the young population worldwide. The primary goal of TBI treatment is to control intracranial pressure (ICP) and to prevent he devastating effect of secondary brain insult. For over a hundred years decompressive craniectomy has been a standard surgical intervention for treatment of TBI, however it is not without harm since it causes serious complications including meningitis, subdural hygroma, hydrocephalous and increased reoperation rate. Cisternostomy is the most recently introduced intervention for management of cerebral edema Cisternostomy has proven its efficiency a standalone treatment as an adjunctive to decompressive craniectomy in treatment of severe traumatic brain injury. This review aims at investigating the therapeutic effects of cisternostomy when used independently or as an adjunctive to decompressive craniectomy (DC) across the available randomized clinical trials (RCTs) and non randomized studies of effect intervention (NRSI) sectional studies to optimize the strength of evidence for underpinning the strategy for treatment of traumatic brain injury.Methods and AnalysisWe will conduct the systematic review and meta-analysis by employing the provisions of Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) 2020 guideline and the review protocol has been submitted to International Prospective Register of Systematic Reviews (PROSPERO) for registration before commencement of the study. We will construct the search strategy using the all field terms, medical subheading terms [MeSH Terms] with all permutations combined with Boolean operators such as AND and OR. PubMed, EMBASE, Scopus, COCHRAINE, Web Of Science, Global Index Medicus, Semantic Scholar and Google Scholar electronic databases will be searched.Ethical Consideration and DisseminationThis review will not include any human participant such that the ethical clearance approval is not applicable. The protocol of this review has been registered at PROSPERO IDCRD42023400894. We will disseminate the final report of this review to local and international scientific conferences and The results of this review will be submitted for publication in the Journal of Neurotrauma.
BACKGROUND: Providing acute care to critically ill patients in intensive care unit (ICU) is a global necessity, regardless of health system capacity. The objectives of the present study were to assess the reasons for admission and clinical outcomes of adult patients admitted to general ICU at Hawassa University Comprehensive Specialized Hospital (HUCSH).METHODS: A retrospective study based on a record review of logbook and charts of 310 adult patients admitted to general ICU of HUCSH between April 2012 and April 2017. Both descriptive analysis and inferential statistics were used.RESULTS: The average age was 41 ± 17.9 years (range: 18-100 years). Males accounted 51.6%. The average duration of stay in the ICU was 5.3 ± 6.7 days (range 1- 49 days). Cardiovascular disorders were the commonest cause of admission, accounted for 22.9%, followed by neurological disorders (17.7%), and trauma related illnesses (13.9%). Among 310 adults admitted during the study period, 23.1% required mechanical ventilator support; and 5.3% developed Hospital acquired infection. In-patient mortality rate was 45.8%. In multivariate analysis, the presences of aspiration pneumonia, and need for ventilator support, acute kidney injury, hospital acquired infection, and short ICU stays were associated with ICU mortality.CONCLUSION: The present study indicates high prevalence of ICU mortality among adults admitted to HUCSH during the study period. ICU mortality was associated with the presences of renal failure, hospital acquired infections, aspiration pneumonia and the need for mechanical ventilator.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.